| Patents for C07D 205 - Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom (6,868) |
|---|
| 08/14/2008 | WO2008096372A2 Process for preparing highly pure ezetimibe using novel intermediates |
| 08/14/2008 | US20080194537 Tetrapeptide capable of inhibiting binding of the Smac protein to Inhibitors of apoptosis, thus promoting apoptosis or sensitizing cells; antiproliferative and anticarcinogenic agents |
| 08/14/2008 | US20080194536 Cyanoarylamines |
| 08/14/2008 | US20080194494 4-Biarylyl-1-Phenylazetidin-2-One Glucuronide Derivatives for Hypercholesterolemia |
| 08/13/2008 | EP1954673A1 Hydroxy-substituted diphenylazetidinones for the treatment of hyperlipidaemia |
| 08/13/2008 | EP1753763B1 Indazole and indolone derivatives and their use as pharmaceuticals |
| 08/13/2008 | EP1453501B1 N- aryl-n'-arylcycloalkyl-urea derivatives as mch antagonists for the treatment of obesity |
| 08/13/2008 | CN101243045A New 2-azetidinone derivatives for the treatment of hyperlipidaemic diseases |
| 08/13/2008 | CN101243044A Novel 2-azetidinone derivatives as cholesterol absorption inhibitors for the treatment of hyperlipidaemic conditions |
| 08/13/2008 | CN100410250C Spiroheterocyclic compoundsus reversible inhibitors of cysteine proteases |
| 08/07/2008 | WO2008057948A3 Processes for production of diphenylylazetidin-2-ones and related compounds |
| 08/07/2008 | US20080187594 Dosage Form With Improved Release Of Cefuroximaxetil |
| 08/06/2008 | EP1953140A1 Process for the preparation of ezetimibe and derivatives thereof |
| 08/06/2008 | EP1311475B1 Aminocyclohexane derivatives |
| 08/06/2008 | CN101238098A Beta-lactam synthesis |
| 08/06/2008 | CN101238097A Resolution of enantiomeric mixtures of beta-lactams |
| 08/05/2008 | US7407938 1,4-Diphenyl-3-(3-hydroxy-3-phenylpropyl)-2-azetidinones, e.g., 2,3,4,5,6-Pentahydroxyhexylamide of 4-(4-{4-[3-[3-(4-fluorophenyl)-3-hydroxypropyl]-2-(4-methoxyphenyl)-4-oxoazetidin-1-y]lbenzylcarbamoyl}phenoxy)benzoic acid; antilipemic agents that have intestinal absorption of less than 10%, |
| 07/31/2008 | WO2008089984A2 Process for the preparation of ezetimibe and derivatives thereof |
| 07/30/2008 | EP1948629A1 Substituted piperazines and piperidines as modulators of the neuropeptide y2 receptor |
| 07/24/2008 | US20080176898 Leukotriene antagonists; cardiovascular disorders like unstable angina pectoris or myocardial infarction; Methyl 1-{[5-(ethoxycarbonyl)-2-(3-{4-[(4-isopropoxybenzyl)oxy]phenyl}propoxy)phenyl]-acetyl}piperidine-4-carboxylate |
| 07/23/2008 | CN101228123A Novel 2-azetidinone derivatives and their use as cholesterol absorption inhibitors for the treatment of hyperlipidaemia |
| 07/22/2008 | US7402670 Synthesis by chiral diamine-mediated asymmetric alkylation |
| 07/16/2008 | EP1943217A1 Compounds comprising a lactam or a lactam derivative moiety, processes for making them, and their uses |
| 07/16/2008 | EP1660445A4 Lactams of alkylated acyclic diamine derivatives as modulators of chemokine receptor activity |
| 07/16/2008 | EP1517890B1 Cationically substituted diphenyl azetidinones, method for their production, medicaments containing said compounds and use thereof |
| 07/16/2008 | CN101222950A Processes for production of 4-(biphenylyl)azetidin-2-one phosphonic acids |
| 07/16/2008 | CN100402025C Modified release pharmaceutical formulation |
| 07/10/2008 | US20080167288 Substituted cyclic hydroxamates as lnhibitors of matrix metalloproteinases |
| 07/10/2008 | US20080167255 4-biarylyl-1-phenylazetidin-2-ones |
| 07/09/2008 | EP1940845A1 Novel azetidine compounds useful in the treatment of functional gastrointestinal disorders, ibs and functional dyspepsia |
| 07/09/2008 | EP1940786A1 Biphenyl derivatives and their use in treating hepatitis c |
| 07/08/2008 | CA2092868C Process for producing 4-substituted azetidinone derivatives |
| 07/03/2008 | US20080161281 Amino-Substituted Tricyclic Derivatives and Methods of Use |
| 07/03/2008 | CA2672727A1 Sphingosine-1-phosphate receptor agonist and antagonist compounds |
| 07/02/2008 | EP1939174A1 Inclusion complex of ezetimibe and a cyclodextrin and processes in the preparation thereof |
| 07/02/2008 | EP1937636A1 Processes for the purification of (3r,4s)-4-(4-hydroxy-protected-phenyl)-1-(4-fluorophenyl)-3-(4-fluorophenyl)-3-oxopropyl¨azetidin-2-one |
| 07/02/2008 | CN101213170A Process for production of 4-biphenylylazetidin-2-ones |
| 06/26/2008 | WO2008076042A1 Azetidinpiperazine derivatives that are neurokinin (nk) receptor antagonists and their use. |
| 06/26/2008 | WO2008075005A1 Quinuclidinol derivatives as muscarinic receptor antagonists |
| 06/26/2008 | WO2008074723A1 Inclusion complex of ezetimibe and a cyclodextrin and processes in the preparation thereof |
| 06/26/2008 | WO2008074703A1 Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives |
| 06/26/2008 | US20080154034 4-alkenyl-2-azetidinone derivatives, process for preparing 4-alkenyl-2-azetidinone derivatives and multicyclic compounds prepared using 4-alkenyl-2-azetidinone derivatives |
| 06/26/2008 | CA2671378A1 Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives |
| 06/25/2008 | EP1934175A2 Anti-hypercholesterolemic compounds |
| 06/25/2008 | EP1934174A1 Azetidines as mek inhibitors for the treatment of proliferative diseases |
| 06/25/2008 | EP1193253B1 Process for producing optically active azetidine-2-carboxylic acids |
| 06/25/2008 | CN101208327A New azetidine derivatives as neurokinin receptor antagonists for the treatment of gastrointestinal diseases |
| 06/24/2008 | US7390790 Antilipemic agents; anticholesterol agents, for example, 2,3,4,5,6-Pentahydroxyhexylamide of 4-(4-{4-[3-[3-(4-fluorophenyl)-3-hydroxypropyl]-2-(4-methoxyphenyl)-4-oxoazetidin-1-yl]benzylcarbamoyl}phenoxy)benzoic acid |
| 06/19/2008 | WO2008072032A1 Transdermal delivery systems of beta-lactam antibiotics |
| 06/19/2008 | CA2671938A1 Transdermal delivery systems of beta-lactam antibiotics |
| 06/18/2008 | CN101200443A Nitrogen heterocyclic methyl ethyl ketone derivatives, preparation method and medicine combination containing the same |
| 06/17/2008 | US7388004 4-{4-[3-[3-(4-Fluorophenyl)-3-hydroxypropyl]-2-(4-methoxyphenyl)-4-oxoazetidin-1-yl]benzylamino}butane-1-sulfonic acid; antilipemic, antidiabetic and hypoglycemic agents; insulin resistance |
| 06/12/2008 | WO2008068475A1 New crystalline forms |
| 06/12/2008 | CA2670678A1 New crystalline forms |
| 06/11/2008 | EP1928821A1 Carboxamide derivatives as muscarinic receptor antagonists |
| 06/11/2008 | EP1414794B1 Allylmercaptocaptopril compounds and uses thereof |
| 06/11/2008 | CN101198338A Anti-hypercholesterolemic compounds |
| 06/11/2008 | CN101195598A Effective production process for mugineic acid compound |
| 06/10/2008 | CA2225896C Process for the production of enantiomerically-pure azetidine-2-carboxylic acid |
| 06/05/2008 | US20080132480 Biphenyloxyacetic Acid Derivatives for the Treatment of Respiratory Disease |
| 06/04/2008 | EP1927588A2 Process for producing optically active azetidine-2-carboxylic acids |
| 06/04/2008 | CN101193859A The preparation and use of compounds as protease inhibitors |
| 05/28/2008 | EP1924549A1 Direct aminolysis |
| 05/27/2008 | US7378518 Vascular conditions such as atherosclerosis, hypercholesterolemia, diabetes, obesity, stroke, demyelination; lowering plasma levels of sterols and/or stanols |
| 05/27/2008 | US7378440 Antidiabetic agents; therapy for insulin resistance |
| 05/27/2008 | US7378409 Substituted cycloalkylamine derivatives as modulators of chemokine receptor activity |
| 05/22/2008 | WO2008061238A2 Processes for production of 4-biphenylyazetidin-2-ones |
| 05/22/2008 | WO2008059782A1 Effective production process for mugineic acid compound |
| 05/22/2008 | WO2007147770A3 Substituted phenyl methanone derivatives |
| 05/22/2008 | CA2669629A1 Efficient method for producing mugineic acids |
| 05/21/2008 | EP1922304A2 Processes for the preparation of (3r,4s)-4-((4-benzyloxy)phenyl)-1-(4-fluorophenyl)-3-((s)-3-(4-fluorophenyl)-3-hydroxypropyl)-2-azetidinone, an intermediate for the synthesis of ezetimibe |
| 05/21/2008 | CN100388918C Pharmaceutical compositions based on azetidine derivatives |
| 05/15/2008 | US20080113976 asthma, multiple sclerosis, artherosclerosis, and rheumatoid arthritis; Azetidine-1-carboxylic acid {2-[({2-hydroxy-1-[(isopropyl-methyl-amino)-methyl]-pentylcarbamoyl}-methyl)-carbamoyl]-4-trifluoromethyl-phenyl}-amide |
| 05/08/2008 | WO2008052658A1 Novel diphenylazetidinone substituted by piperazine-1-sulfonic acid having improved pharmacological properties |
| 05/08/2008 | US20080108595 Inhibitors of cathepsin s |
| 05/08/2008 | CA2668094A1 Novel diphenylazetidinone substituted by piperazine-1-sulfonic acid and having improved pharmacological properties |
| 05/07/2008 | CN101175722A Azetidine derivatives as ccr-3 receptor antagonists |
| 05/07/2008 | CN101172962A Novel intermediate for carbapenem compound for oral administration and process for producing the same |
| 05/07/2008 | CN100386314C Pharmaceutical compositions containing azetidine derivatives novel azetidine derivatives and preparation thereof |
| 05/06/2008 | US7368563 Treatment of atherosclerosis, hypercholesterolemia diabetes, obesity, stroke, alzheimer's, demyelination and lowering plasma levels of sterols |
| 05/06/2008 | US7368562 Treatment of atherosclerosis, hypercholesterolemia diabetes, obesity, stroke, demyelination and lowering plasma levels of sterols |
| 05/02/2008 | WO2007144503A3 Novel process for preparing nitrones and n-hydroxylamines comprising at least one hydroxyl group, and products thus obtained |
| 04/30/2008 | CN101171230A Heterocyclic-substituted alkanamides useful as renin inhibitors |
| 04/29/2008 | US7365061 Antidiabetic agents, anticancer, non-cardiac ischemia, infection, hypertension, obesity and dislipidemia; 3-(5-chloroindole-2-carbonylamino)-2-hydroxy-1,2,3,4-tetrahydronaphthalene |
| 04/29/2008 | CA2321188C Derivatives of azetidine and pyrrolidine |
| 04/29/2008 | CA2254833C Pharmaceutical for treatment of neurological and neuropsychiatric disorders |
| 04/24/2008 | WO2007030721A9 Processes for the preparation of (3r,4s)-4-((4-benzyloxy)phenyl)-1-(4-fluorophenyl)-3-((s)-3-(4-fluorophenyl)-3-hydroxypropyl)-2-azetidinone, an intermediate for the synthesis of ezetimibe |
| 04/23/2008 | EP1912937A1 Novel substituted azetidinones |
| 04/22/2008 | US7361666 Ligands for cellular receptors, including opiate receptors; side effect reduction; base structure is a saturated nitrogen-containing ring substituted with a tertiary amide that is N-substituted with an arylalkyl group |
| 04/17/2008 | WO2007147771A3 Tetralin and indane derivatives and uses thereof |
| 04/17/2008 | WO2007144780A3 Processes for preparing ezetimibe and intermediate compounds useful for the preparation thereof |
| 04/17/2008 | US20080090800 Mandelic acid derivatives and their use as thrombin inhibitors |
| 04/17/2008 | US20080090797 tert-Butyl[3-(4-phenyloxazolidin-2-on-3-yl)-4-(2-styryl)azetidin-2-on-1-yl]acetate; known as synthetic intermediates for the preparation of beta -lactam antibiotics; diuretic |
| 04/16/2008 | EP1911350A1 Amidine compound and herbicide |
| 04/15/2008 | US7358093 Aztreonam L-lysine and methods for the preparation and analysis thereof |
| 04/10/2008 | WO2007060448A3 Chemical process for the preparation of an amido-phenoxybenzoic acid compound |
| 04/10/2008 | US20080085884 Eating disorders, psychological disorders, sexual disorders, nervous system disorders, sleep disorders, autism; 4-(Benzyloxy)-6'-[3-methyl-3-(methylamino)pyrrolidin-1-yl]-2H-1,3'-bipyridin-2-one for example |
| 04/09/2008 | EP1727793B1 Substituted azetidine compounds as cyclooxygenase-1 - cyclooxygenase-2 inhibitors, and their preparation and use as medicaments |
| 04/09/2008 | CN101157647A Method for synthesizing carbapenem antibiotic medicine intermediate |
| 04/01/2008 | US7351825 4-[5-((1S,2R)-1-Carboxy-2-phenyl-cyclopropylsulfamoyl)-thiophen-2-yl]-3,6-dihydro-2H-pyridine-1-carboxylic acid tert-butyl ester; aggrecanase and matrix metalloproteinase (with zinc in the catalytic active center) (MMP) inhibitor; antiarthritic agent: osteoarthritis, rheumatoid arthritis |